Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Contents

Current Drug Targets, Volume 16 - Number 4



CYLD-Mediated Signaling and Diseases

, 16(4): 284 - 294

Bryan J. Mathis, Yimu Lai, Chen Qu, Joseph S. Janicki and Taixing Cui


DOI: 10.2174/1389450115666141024152421



The Role of Adipocytokines in Atherogenesis and Atheroprogression

, 16(4): 295 - 320

Federico Carbone, Francois Mach and Fabrizio Montecucco


DOI: 10.2174/1389450115666141109213439



Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability

, 16(4): 321 - 333

Federico Carbone, Francois Mach and Fabrizio Montecucco


DOI: 10.2174/1389450115666141110093013






Indoxyl Sulfate: A Candidate Target for the Prevention and Treatment of Cardiovascular Disease in Chronic Kidney Disease

, 16(4): 366 - 372

Chiara Barisione, Giorgio Ghigliotti, Marco Canepa, Manrico Balbi, Claudio Brunelli and Pietro Ameri


DOI: 10.2174/1389450116666141230114500







Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog